Serpentine fibula-polycystic kidneys syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2853
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Serpentine fibula-polycystic kidneys syndrome (also known as serpentine fibula-polycystic kidney syndrome or Hajdu-Cheney-like syndrome) is an extremely rare genetic skeletal disorder characterized by the combination of unusually shaped (S-shaped or serpentine) fibulae and polycystic kidneys. The condition primarily affects the skeletal system and the kidneys. Key skeletal features include the distinctive serpentine curvature of the fibula bones in the lower legs, as well as other skeletal anomalies that may include irregular ossification, gracile or thin bones, and facial dysmorphism. Renal involvement manifests as bilateral polycystic kidneys, which can impair kidney function over time. Additional clinical features that have been reported in affected individuals include short stature, characteristic facial features, and other developmental skeletal abnormalities. The condition has been described in only a very small number of patients in the medical literature, making it one of the rarest recognized genetic syndromes. Some cases have been linked to mutations in the NOTCH2 gene, which is also associated with Hajdu-Cheney syndrome, suggesting potential overlap or allelism between these conditions. There is no specific cure or targeted therapy for serpentine fibula-polycystic kidneys syndrome. Management is supportive and symptom-based, involving orthopedic monitoring and intervention for skeletal complications, nephrology follow-up for kidney cyst progression and renal function, and multidisciplinary care to address any additional manifestations. Early detection and regular monitoring of kidney function are important to manage potential renal complications.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Serpentine fibula-polycystic kidneys syndrome.

View clinical trials →

No actively recruiting trials found for Serpentine fibula-polycystic kidneys syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Serpentine fibula-polycystic kidneys syndrome community →

No specialists are currently listed for Serpentine fibula-polycystic kidneys syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Serpentine fibula-polycystic kidneys syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Serpentine fibula-polycystic kidneys syndromeForum →

No community posts yet. Be the first to share your experience with Serpentine fibula-polycystic kidneys syndrome.

Start the conversation →

Latest news about Serpentine fibula-polycystic kidneys syndrome

No recent news articles for Serpentine fibula-polycystic kidneys syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Serpentine fibula-polycystic kidneys syndrome

What is Serpentine fibula-polycystic kidneys syndrome?

Serpentine fibula-polycystic kidneys syndrome (also known as serpentine fibula-polycystic kidney syndrome or Hajdu-Cheney-like syndrome) is an extremely rare genetic skeletal disorder characterized by the combination of unusually shaped (S-shaped or serpentine) fibulae and polycystic kidneys. The condition primarily affects the skeletal system and the kidneys. Key skeletal features include the distinctive serpentine curvature of the fibula bones in the lower legs, as well as other skeletal anomalies that may include irregular ossification, gracile or thin bones, and facial dysmorphism. Renal i

How is Serpentine fibula-polycystic kidneys syndrome inherited?

Serpentine fibula-polycystic kidneys syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Serpentine fibula-polycystic kidneys syndrome typically begin?

Typical onset of Serpentine fibula-polycystic kidneys syndrome is neonatal. Age of onset can vary across affected individuals.